NEW YORK, Oct. 9-Due to unexpectedly strong sales of MALDI TOF and MALDI TOF-TOF machines to academic researchers and medical schools, Bruker Daltonics president and CEO Frank Laukien said today at the UBS Warburg global life sciences conference that he expects respectable revenue growth for the company despite the faltering economy.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.